| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Revenue | $364K | — |
| Cost of Revenue | $88K | — |
| Gross Profit | $276K | — |
| R&D Expense | $171K | -0.9% |
| SG&A Expense | $717K | -12.0% |
| Operating Income | -$612K | +38.0% |
| Interest Expense | $1K | -91.3% |
| Pre-tax Income | -$631K | +36.6% |
| Net Income | -$631K | +36.6% |
| EPS (Basic) | -$0.03 | -103.0% |
| EPS (Diluted) | -$0.03 | -103.0% |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $27K | +62.9% |
| Current Assets | $37K | +0.1% |
| Total Assets | $188K | +414.6% |
| Current Liabilities | $904K | -22.3% |
| Total Liabilities | $994K | -14.6% |
| Stockholders' Equity | -$805K | +28.5% |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$554K | +24.4% |
| Financing Cash Flow | $559K | -24.5% |